Tessera Defense & Homeland Security

HLSQNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$3.223 M

$0.12 -13.89%

Close of 6 Nov 2026

As of 6 Nov 2026, Tessera Defense & Homeland Security (HLSQ) has a market capitalization of $3.22M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$36.2M

Loss-making

Shares outstanding

26,723,870

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#157PharmaCyte BiotechPMCB$4.03M
#158Liminatus PharmaLIMN$3.53M
#159Tessera Defense & Homeland SecurityHLSQ$3.22M
#160VivoSim LabsVIVS$2.41M
#161Calidi BiotherapeuticsCLDI$2.32M

What if Tessera Defense & Homeland Security were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,086,209

Per share 8,759,754× higher

Bitcoin $1.53T

$58,772.90

Per share 473,975× higher

Apple $5.02T

$192,945.96

Per share 1,556,016× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Tessera Defense & Homeland Security are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.